| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NEUROG3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD9 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CA9 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | CYP20A1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | ASB16 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | LARP1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | TINCR | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | PRKCQ | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | FSD1L | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
